Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 39% ± 18% | |
lung | 11 studies | 22% ± 7% | |
peripheral blood | 7 studies | 26% ± 8% | |
liver | 5 studies | 28% ± 12% | |
heart | 4 studies | 20% ± 4% | |
adipose | 4 studies | 21% ± 2% | |
eye | 3 studies | 25% ± 12% | |
intestine | 3 studies | 20% ± 4% | |
kidney | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8045.41 | 1445 / 1445 | 100% | 105.26 | 183 / 183 |
stomach | 100% | 6782.76 | 359 / 359 | 100% | 76.98 | 286 / 286 |
brain | 100% | 14830.04 | 2641 / 2642 | 100% | 158.75 | 705 / 705 |
lung | 100% | 8761.50 | 578 / 578 | 100% | 88.19 | 1154 / 1155 |
intestine | 100% | 7355.80 | 966 / 966 | 99% | 69.31 | 524 / 527 |
skin | 100% | 9341.61 | 1808 / 1809 | 99% | 101.74 | 469 / 472 |
breast | 100% | 6500.04 | 459 / 459 | 99% | 87.99 | 1110 / 1118 |
prostate | 100% | 6355.58 | 245 / 245 | 99% | 76.57 | 498 / 502 |
thymus | 100% | 7459.94 | 653 / 653 | 99% | 104.12 | 599 / 605 |
ovary | 100% | 5711.19 | 180 / 180 | 99% | 52.17 | 425 / 430 |
kidney | 100% | 5472.46 | 89 / 89 | 98% | 101.24 | 887 / 901 |
bladder | 100% | 7339.71 | 21 / 21 | 98% | 61.74 | 494 / 504 |
pancreas | 100% | 4561.21 | 327 / 328 | 98% | 62.42 | 174 / 178 |
uterus | 100% | 7198.31 | 170 / 170 | 97% | 67.77 | 447 / 459 |
adrenal gland | 100% | 8952.89 | 258 / 258 | 91% | 46.89 | 210 / 230 |
liver | 100% | 3488.35 | 225 / 226 | 91% | 43.07 | 368 / 406 |
adipose | 100% | 6863.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9133.76 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 55.61 | 29 / 29 |
spleen | 100% | 8243.53 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 80.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.80 | 1 / 1 |
muscle | 100% | 6165.30 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 10324.65 | 922 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 5072.16 | 829 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 63.10 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0120041 | Biological process | positive regulation of macrophage proliferation |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0038127 | Biological process | ERBB signaling pathway |
GO_0030878 | Biological process | thyroid gland development |
GO_0006935 | Biological process | chemotaxis |
GO_0032872 | Biological process | regulation of stress-activated MAPK cascade |
GO_0019858 | Biological process | cytosine metabolic process |
GO_0035094 | Biological process | response to nicotine |
GO_0006468 | Biological process | protein phosphorylation |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0042473 | Biological process | outer ear morphogenesis |
GO_0038133 | Biological process | ERBB2-ERBB3 signaling pathway |
GO_1904355 | Biological process | positive regulation of telomere capping |
GO_0042552 | Biological process | myelination |
GO_0072584 | Biological process | caveolin-mediated endocytosis |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_0090170 | Biological process | regulation of Golgi inheritance |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0060425 | Biological process | lung morphogenesis |
GO_0060324 | Biological process | face development |
GO_0060716 | Biological process | labyrinthine layer blood vessel development |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_0030521 | Biological process | androgen receptor signaling pathway |
GO_0070849 | Biological process | response to epidermal growth factor |
GO_0033598 | Biological process | mammary gland epithelial cell proliferation |
GO_0051493 | Biological process | regulation of cytoskeleton organization |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0050847 | Biological process | progesterone receptor signaling pathway |
GO_0060440 | Biological process | trachea formation |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0048538 | Biological process | thymus development |
GO_0051973 | Biological process | positive regulation of telomerase activity |
GO_0061308 | Biological process | cardiac neural crest cell development involved in heart development |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_2000641 | Biological process | regulation of early endosome to late endosome transport |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0060020 | Biological process | Bergmann glial cell differentiation |
GO_0007611 | Biological process | learning or memory |
GO_0006974 | Biological process | DNA damage response |
GO_0010759 | Biological process | positive regulation of macrophage chemotaxis |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0014044 | Biological process | Schwann cell development |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0006915 | Biological process | apoptotic process |
GO_0045596 | Biological process | negative regulation of cell differentiation |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_0030278 | Biological process | regulation of ossification |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0030641 | Biological process | regulation of cellular pH |
GO_0031647 | Biological process | regulation of protein stability |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005634 | Cellular component | nucleus |
GO_0005576 | Cellular component | extracellular region |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005770 | Cellular component | late endosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005769 | Cellular component | early endosome |
GO_0005813 | Cellular component | centrosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005901 | Cellular component | caveola |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0031143 | Cellular component | pseudopodium |
GO_0042802 | Molecular function | identical protein binding |
GO_0008353 | Molecular function | RNA polymerase II CTD heptapeptide repeat kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
GO_0004707 | Molecular function | MAP kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0019902 | Molecular function | phosphatase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003677 | Molecular function | DNA binding |
Gene name | MAPK1 |
Protein name | Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) Mitogen-activated protein kinase (EC 2.7.11.24) |
Synonyms | PRKM1 PRKM2 hCG_32557 ERK2 |
Description | FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1 and FXR1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity). .; FUNCTION: Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity. . |
Accessions | ENST00000215832.11 [P28482-1] P28482 Q499G7 ENST00000398822.7 [P28482-1] Q1HBJ4 ENST00000544786.1 [P28482-2] |